Gene · 7517
Papers2,149
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,149
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oxidative stress-driven transcriptomic remodeling in human astrocytes reveals network signatures associated with neurodegenerative and cardiovascular processes. | Comput Struct Biotechnol J | 2026 | 41550140 | PubTator, text mining | PubMed |
| Integrated case-control and in silico analysis of DNA double-strand break repair gene variants (RAD51, XRCC2, XRCC3, XRCC4, and LIG4) for ovarian cancer susceptibility. | Gene | 2026 | 41478437 | PubTator, text mining | PubMed |
| Cryo-electron microscopic visualization of RAD51 filament assembly and end-capping by XRCC3-RAD51C-RAD51D-XRCC2. | Science | 2026 | 41196948 | PubTator, text mining | PubMed |
| Development of a predictive model for neutropenia risk in Japanese breast cancer patients treated with doxorubicin and cyclophosphamide. | Br J Clin Pharmacol | 2026 | 40859847 | PubTator, text mining | PubMed |
| Single-nucleotide polymorphisms in DNA repair genes ERCC, XRCC, and MGMT and implications in glioblastoma: a pathway analysis and structural dynamics study. | J Biomol Struct Dyn | 2026 | 40719684 | PubTator, text mining | PubMed |
| Association Between Seven Selected Genetic Polymorphisms in DNA Repair-Related Genes and Breast Cancer Risk: Evidence from a Comprehensive Meta-analysis Including 96 Studies. | Biochem Genet | 2026 | 40586826 | PubTator, text mining | PubMed |
| Single Nucleotide Polymorphisms as Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Systematic Review. | Cancers (Basel) | 2025 | 41463244 | PubTator, text mining | PubMed |
| A comprehensive compilation of data on the association between XRCC3 polymorphisms and thyroid cancer susceptibility. | BMC Endocr Disord | 2025 | 41094439 | PubTator, text mining | PubMed |
| Transcriptome profiling of human dermal MDPL fibroblasts reveals a characteristic molecular signature providing insights into pathogenic mechanisms. | J Mol Med (Berl) | 2025 | 41083899 | PubTator, text mining | PubMed |
| Genomic characterization of patients with colorectal cancer. | Hered Cancer Clin Pract | 2025 | 41013697 | PubTator, text mining | PubMed |
| Integration of germline pharmacogenomic burden to predict fluoropyrimidine-related toxicity - A secondary analysis of the PREPARE trial. | Oncogene | 2025 | 40999005 | PubTator, text mining | PubMed |
| Genetic Variants Associated with Breast Cancer Are Detected by Whole-Exome Sequencing in Vietnamese Patients. | Diagnostics (Basel) | 2025 | 40941673 | PubTator, text mining | PubMed |
| Expression analysis of C-FOS and XRCC3 Thr241Met polymorphism in gastric cancer. | Cell Mol Biol (Noisy-le-grand) | 2025 | 40920316 | PubTator, text mining | PubMed |
| High-fidelity Cas9-mediated targeting of KRAS driver mutations restrains lung cancer in preclinical models. | Nat Commun | 2025 | 40890128 | PubTator, text mining | PubMed |
| Potential role of Fanconi anemia pathway in the pathogenesis of endometrial cancer (Review). | Mol Med Rep | 2025 | 40849815 | PubTator, text mining | PubMed |
| A Case-Control Study on Combined Effects of Base Excision Repair and Nucleotide Excision Repair Gene Polymorphisms in Gastrointestinal Cancer Susceptibility. | Asian Pac J Cancer Prev | 2025 | 40849707 | PubTator, text mining | PubMed |
| The Prognostic Value of the XPC rs2228001 Single Nucleotide Polymorphism in Cholangiocarcinoma. | Liver Int | 2025 | 40833230 | PubTator, text mining | PubMed |
| TRsv: simultaneous detection of tandem repeat variations, structural variations, and short indels using long read sequencing data. | Genome Biol | 2025 | 40830527 | PubTator, text mining | PubMed |
| Transcription-coupled repair of crosslinking DNA damage. | DNA Repair (Amst) | 2025 | 40706399 | PubTator, text mining | PubMed |
| Biomarker Potential of DNA Repair Genes XRCC1, XRCC3 and RAD51 Polymorphisms in Ovarian Cancer Patients. | Cancer Invest | 2025 | 40610242 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7517/papers?page=2